# ANVISA

Type: organization

Source: Legal & RegTech Intelligence Brief — https://getlegalbrief.com/entity/anvisa-organization
Canonical HTML page: https://getlegalbrief.com/entity/anvisa-organization

## Timeline

- **2026-03-24**: Brazil Patent Grant — Recce Pharmaceuticals officially receives patent grant from the Brazilian National Institute of Industrial Property (INPI).
- **2025-11-15**: Clinical Expansion — Recce expands Phase II clinical trials for RECCE® 327 in topical and intravenous applications.
- **2024-06-10**: US Patent Milestone — Recce secures key composition of matter patents in the United States, strengthening its North American position.

## Recent coverage (1 stories)

### Recce Pharmaceuticals Secures Key Brazilian Patent for Anti-Infective Platform
2026-03-24 03:21:33 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Recce Pharmaceuticals has been granted a critical patent in Brazil for its synthetic anti-infective platform, marking a significant expansion into South America's largest healthcare market. The patent protects the composition and manufacturing of its lead candidates, RECCE® 327 and RECCE® 529, as the company targets the global antimicrobial resistance crisis.
Full story: https://getlegalbrief.com/story/recce-pharmaceuticals-brazil-patent-grant-anti-infectives

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getlegalbrief.com/guides/methodology for the full editorial methodology.